Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Translational Oncology is Scopus-indexed (Q1, CiteScore 7.3), WoS SCIE, DOAJ. Published by Neoplasia Press, Inc..
Checked against the index lists dated .
ISSN 1936-5233Verify ISSN ↗1944-7124Verify ISSN ↗
Publisher: Neoplasia Press, Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 80 / 428 | 81st | Q1 |
| Cancer Research | 71 / 233 | 69th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 7.3.
Translational Oncology is Q1 in Oncology (rank 80 of 428) and Q2 in Cancer Research (rank 71 of 233), by CiteScore 2025.
Translational Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.3, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.383, quartile Q1, with an H-index of 84.
The publisher lists an article processing charge of about US$3,390 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Translational Oncology is published by Neoplasia Press, Inc. Its print ISSN is 1936-5233 and its online ISSN is 1944-7124.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Translational Oncology has an h-index of 96 and a 2-year mean of 4.21 citations per paper (OpenAlex). Its Scopus CiteScore is 7.3, quartile Q1. On 2-year citations it ranks #76 of 424 Scopus journals in Oncology.
Translational Oncology published 378 papers in 2025; its busiest recent year was 2024 with 396. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from China (81.3%), United States (2.8%) and Italy (2.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.